Caspar B Seitz1,2, Amgad Droby1,2, Lena Zaubitzer1, Julia Krämer3, Mathieu Paradis1, Luisa Klotz3, Heinz Wiendl3, Sergiu Groppa1,2, Sven G Meuth3, Frauke Zipp1,2, Vinzenz Fleischer4,5. 1. Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. 2. Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), Johannes Gutenberg University Mainz, Mainz, Germany. 3. Department of Neurology, University of Münster, Albert-Schweizer-Campus, Münster, Germany. 4. Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. vinzenz.fleischer@unimedizin-mainz.de. 5. Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), Johannes Gutenberg University Mainz, Mainz, Germany. vinzenz.fleischer@unimedizin-mainz.de.
Abstract
OBJECTIVE: To evaluate volumetric changes and discriminative power of intra-retinal layers in early-stage multiple sclerosis (MS) using a 3D optical coherence tomography (OCT) imaging method based on an in-house segmentation algorithm. METHODS: 3D analysis of intra-retinal layers was performed in 71 patients with early-stage MS (mean disease duration 2.2 ± 3.5 years) at baseline and 40 healthy controls (HCs). All patients underwent a follow-up OCT scan within 23 ± 9 months. Patients with a clinical episode of optic neuritis (ON) more than 6 months prior to study entrance were compared with patients who never experienced clinical symptoms of an ON episode (NON). RESULTS: Significantly decreased total retinal volume (TRV), macular retinal nerve fiber layer (mRNFL) and ganglion cell-inner plexiform layer (GCIPL) volumes were detected in ON patients compared to NON patients (all p values < 0.05) at baseline. Each parameter on its own allowed identification of prior clinical ON based on a discriminative model (ROC analysis). Over time, TRV decreased in both ON (p = 0.013) and NON patients (p = 0.002), whereas mRNFL volume (p = 0.028) decreased only in ON and GCIPL volume (p = 0.003) decreased only in NON patients. CONCLUSION: Our 3D-OCT data demonstrated that TRV, mRNFL and GCIPL allow discrimination between ON and NON patients in a cross-sectional analysis. However, the subsequent retinal atrophy pattern diverges in the initial phase of MS: Prior ON promotes sustained axonal thinning over time indicated by mRNFL loss, whereas longitudinal measurement of GCIPL volume better depicts continuous retrograde neurodegeneration in NON patients in early-stage MS.
OBJECTIVE: To evaluate volumetric changes and discriminative power of intra-retinal layers in early-stage multiple sclerosis (MS) using a 3D optical coherence tomography (OCT) imaging method based on an in-house segmentation algorithm. METHODS: 3D analysis of intra-retinal layers was performed in 71 patients with early-stage MS (mean disease duration 2.2 ± 3.5 years) at baseline and 40 healthy controls (HCs). All patients underwent a follow-up OCT scan within 23 ± 9 months. Patients with a clinical episode of optic neuritis (ON) more than 6 months prior to study entrance were compared with patients who never experienced clinical symptoms of an ON episode (NON). RESULTS: Significantly decreased total retinal volume (TRV), macular retinal nerve fiber layer (mRNFL) and ganglion cell-inner plexiform layer (GCIPL) volumes were detected in ON patients compared to NON patients (all p values < 0.05) at baseline. Each parameter on its own allowed identification of prior clinical ON based on a discriminative model (ROC analysis). Over time, TRV decreased in both ON (p = 0.013) and NON patients (p = 0.002), whereas mRNFL volume (p = 0.028) decreased only in ON and GCIPL volume (p = 0.003) decreased only in NON patients. CONCLUSION: Our 3D-OCT data demonstrated that TRV, mRNFL and GCIPL allow discrimination between ON and NON patients in a cross-sectional analysis. However, the subsequent retinal atrophy pattern diverges in the initial phase of MS: Prior ON promotes sustained axonal thinning over time indicated by mRNFL loss, whereas longitudinal measurement of GCIPL volume better depicts continuous retrograde neurodegeneration in NON patients in early-stage MS.
Authors: Iñigo Gabilondo; María Sepúlveda; Santiago Ortiz-Perez; Elena Fraga-Pumar; Elena H Martínez-Lapiscina; Sara Llufriu; Nuria Solá; Albert Saiz; Bernardo Sanchez-Dalmau; Pablo Villoslada Journal: J Neurol Neurosurg Psychiatry Date: 2013-05-28 Impact factor: 10.154
Authors: Bernardo Sanchez-Dalmau; Elena H Martinez-Lapiscina; Ruben Torres-Torres; Santiago Ortiz-Perez; Irati Zubizarreta; Irene V Pulido-Valdeolivas; Salut Alba-Arbalat; Ana Guerrero-Zamora; David Calbet; Pablo Villoslada Journal: Mult Scler Date: 2017-07-03 Impact factor: 6.312
Authors: Elena Garcia-Martin; Jose R Ara; Jesus Martin; Carmen Almarcegui; Isabel Dolz; Elisa Vilades; Laura Gil-Arribas; Francisco J Fernandez; Vicente Polo; Jose M Larrosa; Luis E Pablo; Maria Satue Journal: Ophthalmology Date: 2017-02-07 Impact factor: 12.079
Authors: Anna M Pietroboni; Laura Dell'Arti; Michela Caprioli; Marta Scarioni; Tiziana Carandini; Andrea Arighi; Laura Ghezzi; Giorgio G Fumagalli; Milena A De Riz; Paola Basilico; Annalisa Colombi; Eleonora Benatti; Fabio Triulzi; Elio Scarpini; Francesco Viola; Daniela Galimberti Journal: Mult Scler Date: 2017-11-10 Impact factor: 6.312
Authors: E J Lampert; M Andorra; R Torres-Torres; S Ortiz-Pérez; S Llufriu; M Sepúlveda; N Sola; A Saiz; B Sánchez-Dalmau; P Villoslada; Elena H Martínez-Lapiscina Journal: J Neurol Date: 2015-08-11 Impact factor: 4.849
Authors: Elizabeth C Graham; Yuyi You; Con Yiannikas; Raymond Garrick; John Parratt; Michael H Barnett; Alexander Klistorner Journal: Invest Ophthalmol Vis Sci Date: 2016-04-01 Impact factor: 4.799
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: Jan Dörr; Klaus D Wernecke; Markus Bock; Gunnar Gaede; Jens T Wuerfel; Caspar F Pfueller; Judith Bellmann-Strobl; Alina Freing; Alexander U Brandt; Paul Friedemann Journal: PLoS One Date: 2011-04-08 Impact factor: 3.240
Authors: Caspar B Seitz; Falk Steffen; Muthuraman Muthuraman; Timo Uphaus; Julia Krämer; Sven G Meuth; Philipp Albrecht; Sergiu Groppa; Frauke Zipp; Stefan Bittner; Vinzenz Fleischer Journal: Ther Adv Neurol Disord Date: 2021-05-25 Impact factor: 6.570